When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMF - FDA accepts Astellas' marketing application for gilteritinib for AML
Astellas Pharma Inc
The FDA accepts under Priority Review Astellas Pharma's (OTCPK:ALPMF)(OTCPK:ALPMY) marketing application seeking approval for gilteritinib for the treatment of adult patients with relapsed/refractory FLT3-positive acute myeloid leukemia (AML). The agency's action date is November 29.
More news on: Astellas Pharma, Inc., Astellas Pharma, Inc. ADR, Healthcare stocks news,